Inventor
DEISSEROTH ALBERT B
US25 patents
⚠️ This page may combine multiple inventors who share the name “DEISSEROTH ALBERT B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MICROVAX LLC
14 patentsUS10046041B2Aug 14, 2018
Methods and compositions for suppressing virulence of methicillin resistant Staphylococcus aureus
MICROVAX LLC3 citations72
US9353167B2May 31, 2016
Methods for generating immunity to antigen
MICROVAX LLC3 citations70
US12427191B1Sep 30, 2025
SARS-CoV-2 fusion protein vaccine/regimen
MICROVAX LLC0 citations62
US11097001B1Aug 24, 2021
Composition and method against tuberculosis
MICROVAX LLC1 citations62
US10183067B1Jan 22, 2019
TAA/CD4OL composition/vaccine for malaria
MICROVAX LLC1 citations62
US10166284B1Jan 1, 2019
Vaccines for herpes simplex virus 1 and 2
MICROVAX LLC1 citations62
US11839655B2Dec 12, 2023
Combination cancer therapy
MICROVAX LLC1 citations61
US11077183B2Aug 3, 2021
CD40 ligand fusion protein vaccine
MICROVAX LLC0 citations61
US11154603B1Oct 26, 2021
Burkholderia pseudomallei composition
MICROVAX LLC0 citations51
US9642901B1May 9, 2017
TAA/CD40L vaccine for malaria
MICROVAX LLC1 citations51
US9526774B1Dec 27, 2016
Methods and compositions for suppressing virulence of methicillin resistant Staphylococcus aureus
MICROVAX LLC1 citations51
US10426827B1Oct 1, 2019
Dengue hemorrhagic fever virus vaccine
MICROVAX LLC0 citations41
US10293040B1May 21, 2019
Pharmaceutical compositions and methods of blocking Bacillus anthracis
MICROVAX LLC0 citations41
US10174100B1Jan 8, 2019
Multivalent DNA composition for Yersinia pestis
MICROVAX LLC0 citations41
DEISSEROTH ALBERT B
8 patentsUS8119117B2Feb 21, 2012
Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity
DEISSEROTH ALBERT B37 citations95
US8236295B1Aug 7, 2012
Composition comprising an adenoviral expression vector comprising a CD40L fusion protein for generating immune responses
DEISSEROTH ALBERT B9 citations83
US8540979B2Sep 24, 2013
Methods of generating immune responses with compositions comprising an adenoviral expression vector comprising a CD40L fusion protein
DEISSEROTH ALBERT B4 citations73
US10130667B1Nov 20, 2018
TAA/ecdCD40L oncolytic virus
DEISSEROTH ALBERT B3 citations72
US10383932B2Aug 20, 2019
Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD4OL/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells
DEISSEROTH ALBERT B1 citations61
US10835589B2Nov 17, 2020
Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD40L/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells
DEISSEROTH ALBERT B0 citations51
US10149899B1Dec 11, 2018
Composition and method against C-difficile
DEISSEROTH ALBERT B0 citations40
US9889188B1Feb 13, 2018
Ebola virus composition/vaccine
DEISSEROTH ALBERT B0 citations40